Catherine Schulte
Stock Analyst at Baird
(2.11)
# 1158
Out of 5,240 analysts
125
Total ratings
59.60%
Success rate
15.64%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Mettler-Toledo Intl | Maintains: Neutral | 1375 1310 | 1292.96 | 1.32% | 6 | Nov 11, 2024 | |
Maravai LifeSciences | Maintains: Outperform | 10 9 | 4.71 | 91.08% | 4 | Nov 8, 2024 | |
Exact Sciences | Maintains: Outperform | 70 67 | 55.63 | 20.44% | 13 | Nov 6, 2024 | |
Bio-Techne | Maintains: Outperform | 82 84 | 76.65 | 9.59% | 8 | Oct 31, 2024 | |
Avantor | Maintains: Outperform | 27 26 | 21.75 | 19.54% | 10 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 632 622 | 560.54 | 10.96% | 25 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 278 277 | 240.31 | 15.27% | 6 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 49 52 | 46.01 | 13.02% | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 147 136 | 145.52 | -6.54% | 14 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 182 165 | n/a | n/a | 6 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 25.95 | 46.44% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 56 33 | 46.12 | -28.45% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | n/a | n/a | 1 | Jun 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 335 281 | 138.78 | 102.48% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | May 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 29 | n/a | n/a | 5 | Apr 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 208 217 | 407.98 | -46.81% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 17 20 | 169.09 | -88.17% | 1 | Jun 28, 2018 |